BIOTIME
BIOTIME operates in Diversified Metals & Mining.
Market Cap & Net Worth: BIOTIME (BT3)
BIOTIME (BE:BT3) has a market capitalization of $13.70K (€13.34K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #44592 globally and #7323 in its home market, demonstrating a -10.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIOTIME's stock price €1.35 by its total outstanding shares 9883 (9.88K).
BIOTIME Market Cap History: 2015 to 2025
BIOTIME's market capitalization history from 2015 to 2025. Data shows change from $116.96K to $13.70K (-17.80% CAGR).
BIOTIME Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIOTIME's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
BIOTIME's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $106.21K | $5.92 Million | $33.57 Million | 0.02x | 0.00x |
| 2017 | $56.24K | $3.46 Million | -$19.98 Million | 0.02x | N/A |
| 2018 | $24.74K | $4.99 Million | -$45.99 Million | 0.00x | N/A |
| 2019 | $6.81K | $3.52 Million | -$11.71 Million | 0.00x | N/A |
| 2020 | $13.59K | $773.00K | -$20.65 Million | 0.02x | N/A |
| 2021 | $21.71K | $3.90 Million | -$43.02 Million | 0.01x | N/A |
| 2022 | $11.71K | $14.70 Million | -$26.27 Million | 0.00x | N/A |
| 2023 | $10.25K | $8.95 Million | -$21.49 Million | 0.00x | N/A |
Competitor Companies of BT3 by Market Capitalization
Companies near BIOTIME in the global market cap rankings as of March 19, 2026.
Key companies related to BIOTIME by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
BIOTIME Historical Marketcap From 2015 to 2025
Between 2015 and today, BIOTIME's market cap moved from $116.96K to $ 13.70K, with a yearly change of -17.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €13.70K | +192.21% |
| 2024 | €4.69K | -54.26% |
| 2023 | €10.25K | -12.52% |
| 2022 | €11.71K | -46.05% |
| 2021 | €21.71K | +59.70% |
| 2020 | €13.59K | +99.70% |
| 2019 | €6.81K | -72.49% |
| 2018 | €24.74K | -56.01% |
| 2017 | €56.24K | -47.05% |
| 2016 | €106.21K | -9.19% |
| 2015 | €116.96K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of BIOTIME was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.70K USD |
| MoneyControl | $13.70K USD |
| MarketWatch | $13.70K USD |
| marketcap.company | $13.70K USD |
| Reuters | $13.70K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.